BIC : Résultats du 1er trimestre 2024
23 avr. 2024 11h42 HE
|
Societe BIC
Clichy, France – le 23 avril 2024 RÉSULTATS DU 1er TRIMESTRE 20241 Chiffre d’affaires stable à taux de change constants hors Argentine.Perspectives 2024...
BIC: First Quarter 2024 Results
23 avr. 2024 11h42 HE
|
Societe BIC
Clichy, France – April 23, 2024 FIRST QUARTER 2024 RESULTS1 Flat net sales at constant currency excl. Argentina. Full-year outlook confirmed.Strong Free Cash Flow...
Ero Copper to Release First Quarter 2024 Operating and Financial Results on May 7, 2024
11 avr. 2024 17h05 HE
|
Ero Copper Corp.
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its first quarter 2024 operating and financial results on...
Goodfellow annonce ses résultats pour son premier trimestre terminé le 29 février 2024
11 avr. 2024 17h00 HE
|
Goodfellow inc.
DELSON, Québec, 11 avr. 2024 (GLOBE NEWSWIRE) -- Goodfellow inc. (TSX : GDL) (la « Société » ou « Goodfellow ») annonce aujourd’hui ses résultats financiers pour le premier trimestre terminé le...
Goodfellow Reports Its Results for the First Quarter Ended February 29, 2024
11 avr. 2024 17h00 HE
|
Goodfellow Inc.
GOODFELLOW REPORTS ITS RESULTS FOR THE FIRST QUARTER ENDED 02-29-2024. / GOODFELLOW ANNONCE SES RÉSULTATS POUR SON PREMIER TRIMESTRE TERMINÉ 02-29-2024
Aedifica NV/SA: 2023 Annual Report
04 avr. 2024 02h00 HE
|
Aedifica
Download Aedifica’s 2023 Annual Report by clicking on the link below.
Attachments
Annual Report (EN)
Rapport Annuel (FR)
...
SuRo Capital Corp. Announces Expiration and Final Results of Tender Offer
03 avr. 2024 09h00 HE
|
SuRo Capital Corp.
NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq: SSSS) today announced its final results from its modified “Dutch Auction” tender offer (the...
Annual results 2023: Record business generates solid results and confirms the attractiveness of the AFL model
02 avr. 2024 09h18 HE
|
Agence France Locale
Annual results 2023: Record business generates solid results and confirms the attractiveness of the AFL model At 31 December 2023, the AFL Group reported a sharp improvement in results: The...
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
02 avr. 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101
22 mars 2024 07h00 HE
|
OKYO Pharma LTD
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief